Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 10NIH 4NETWORK 3INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Carcinoma, Non-Small-Cell Lung 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Multiple Myeloma 5Breast Neoplasms 5Wilms Tumor 4Prostatic Neoplasms 4Neoplasms 4Hematologic Neoplasms 4Burkitt Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Plasmablastic Lymphoma 3Pancreatic Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma 3HIV Infections 3Ependymoma 3Colorectal Neoplasms 3Astrocytoma 3Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Melanoma 2Medulloblastoma 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Hodgkin Disease 2Head and Neck Neoplasms 2

Interventions

vorasidenib 1Specimen Handling 1Radiotherapy 1Radiation 1Magnetic Resonance Spectroscopy 1AZD1390 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Astrocytoma × 30 days × Clear all
NCT04978727 2026-06-02

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Children's Oncology Group

Phase 1 Active not recruiting
35 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Ependymoma, Glioblastoma, Medulloblastoma, Oligodendroglioma

NCT06809322 2026-05-22

VIGOR

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
468 enrolled
CNS

Astrocytoma

NCT06894979 2026-05-15

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Children's Oncology Group

Phase 1 Recruiting
54 enrolled
CNS

Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡